Looking at the Diabetes Research Institute's BioHubTuesday, November 11, 2014
The Diabetes Research Institute has been working on its BioHub, which is a bioengineered organ for treatment of type 1 diabetes. Here is a closer look at this exciting technology as it begins clinical trials.
The Liver is not an Ideal Home for Islets
Researchers have been transplanting islet cells into the liver to restore natural insulin production in those with type 1 diabetes. Some patients have been living without the need for insulin injections for more than a decade. Despite these achievements, over time, many of the cells are lost and patients must resume insulin therapy. That’s because the liver is not an ideal home for the cells.